The DPP-4 Inhibitor Linagliptin Improves Cardiac Function in GLP-1 Receptor Knockout Mice with Hypertrophic Heart Failure

被引：0
|
作者：
Batchu, Sri N.
Kabir, Golam
Klein, Thomas
Connelly, Kim A.
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
485-P
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [1] The neuroprotective efficacy of the DPP-4 inhibitor linagliptin against stroke is not mediated by GLP-1 receptor activation
    Darsalia, V.
    Larsson, M.
    Nathanson, D.
    Drucker, D. J.
    Nystrom, T.
    Klein, T.
    Patrone, C.
    DIABETOLOGIA, 2015, 58 : S35 - S35
  • [2] The DPP-4 Inhibitor Linagliptin Restores β-Cell Function and Survival in Human Isolated Islets Through GLP-1 Stabilization
    Shah, Payal
    Ardestani, Amin
    Dharmadhikari, Gitanjali
    Laue, Svenja
    Schumann, Desiree M.
    Kerr-Conte, Julie
    Pattou, Francois
    Klein, Thomas
    Maedler, Kathrin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (07): : E1163 - E1172
  • [3] Impact of Either GLP-1 Agonists or DPP-4 Inhibitors on Pathophysiology of Heart Failure
    Takahashi, Ayako
    Ihara, Madoka
    Yamazaki, Satoru
    Asanuma, Hiroshi
    Asakura, MaSarlori
    Kitakaze, Masafumi
    INTERNATIONAL HEART JOURNAL, 2015, 56 (04) : 372 - 376
  • [4] Gastrointestinal and Renal Effects of 3 Months of Treatment with GLP-1 Receptor Agonist Exenatide and DPP-4 Inhibitor Linagliptin: The SAFEGUARD Trial
    Mraz, Milos
    Klouckova, Jana
    Kavalkova, Petra
    Trachta, Pavel
    Krizova, Jarmila
    Kosak, Mikulas
    Kurzova, Ivana
    Kocna, Petr
    Haluzik, Martin
    DIABETES, 2016, 65 : A284 - A284
  • [5] Mechanisms of GLP-1 receptor-independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomy
    Hasan, Ahmed A.
    von Websky, Karoline
    Reichetzeder, Christoph
    Tsuprykov, Oleg
    Gaballa, Mohamed M. S.
    Guo, Jingli
    Zeng, Shufei
    Delic, Denis
    Tammen, Harald
    Klein, Thomas
    Kleuser, Burkhard
    Hocher, Berthold
    KIDNEY INTERNATIONAL, 2019, 95 (06) : 1373 - 1388
  • [6] Effects of GLP-1 receptor analogue liraglutide and DPP-4 inhibitor vildagliptin on the bone metabolism in ApoE-/- mice
    Zhang, Lizhi
    Li, Peicheng
    Tang, Zhaosheng
    Dou, Qin
    Feng, Bo
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (16)
  • [7] Cardiovascular Effects of 3 Months of Treatment with GLP-1 Receptor Agonist Exenatide and DPP-4 Inhibitor Linagliptin: The SAFE-GUARD Trial
    Mraz, Milos
    Chytilova, Eva
    Klouckova, Jana
    Trachta, Pavel
    Skrha, Jan, Jr.
    Krizova, Jarmila
    Petrak, Ondrej
    Krupicka, Jan
    Tuka, Vladimir
    Kudlicka, Jaroslav
    Kratka, Zuzana
    Dostalova, Gabriela
    Malik, Jan
    Haluzik, Martin
    DIABETES, 2016, 65 : A284 - A284
  • [8] GLP-1 Receptor Independent Effects of DPP-4 Inhibition in Mice with 5/6 Nephrectomy
    Hasan, Ahmed Abdallah
    Reichetzeder, Christoph
    Guo, Jingli
    Von Websky, Karoline
    Tsuprykov, Oleg
    Klein, Thomas
    Hocher, Berthold
    DIABETES, 2016, 65 : A132 - A132
  • [9] GLP-1 receptor independent effects of DPP-4 inhibition in mice with 5/6 nephrectomy
    Hocher, B.
    Hasan, A.
    Reichetzeder, C.
    Guo, J.
    von Websky, K.
    Tsuprykov, O.
    Klein, T.
    DIABETOLOGIA, 2016, 59 : S509 - S510
  • [10] The DPP-4 Inhibitor Linagliptin Significantly Improves Insulin Sensitivity in Diet Induced Obese Mice
    Kern, Matthias
    Kloeting, Nora
    Klein, Thomas
    Mark, Michael
    Blueher, Matthias
    DIABETES, 2010, 59 : A577 - A577
12345